Pharmacokinetics, Pharmacodynamics, and Safety of Dulaglutide After Single or Multiple Doses in Chinese Healthy Subjects and Patients with T2DM: A Randomized, Placebo-Controlled, Phase I Study.
Junyu XuYifei ZhangYiming LiXia ZhaoWeiwei ZhouCorina LoghinLai San ThamXuewei CuiYi Min CuiWeiqing WangPublished in: Advances in therapy (2021)
NCT01667900 (ClinicalTrials.gov).